• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明胶-甲氨蝶呤共轭微球作为一种潜在的药物递送系统。

Gelatin-methotrexate conjugate microspheres as a potential drug delivery system.

作者信息

Pica Karen, Tchao Ruy, Ofner Clyde M

机构信息

Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, Pennsylvania, USA.

出版信息

J Pharm Sci. 2006 Sep;95(9):1896-908. doi: 10.1002/jps.20572.

DOI:10.1002/jps.20572
PMID:16850436
Abstract

Gelatin-methotrexate microspheres for intra-tumor administration have possibilities for minimizing systemic toxicities of methotrexate (MTX) and overcoming its resistance. Gelatin-MTX conjugates prepared by a carbodiimide reaction were crosslinked with glutaraldehyde to form microspheres (MTX:gelatin molar ratios of 2:1, 15:1, and 21:1). Microspheres were evaluated under in vitro tumor conditions at pH 6.5 and 37 degrees C with and without Cathepsin B (Cat B). Some microspheres were capped with an ethanolamine/cyanoborohydride procedure. SEM of broken microspheres revealed a hollow shell structure. Superficial Cat B degradation influenced some free MTX release but produced no conjugate fragment release. HPLC measured release of fragments (<10 kDa) was very little and release of free MTX was small. However, higher drug load microspheres released less free MTX than lower drug load, a substantial lag phase of free MTX release from capped microspheres changed to an initial rapid release in uncapped microspheres, and fragments were only released from uncapped microspheres. Opened unstable Schiff base crosslinks in uncapped microspheres may allow enzyme to produce conjugate fragments not observed in capped microspheres. Free MTX release may occur from dissolved uncrosslinked conjugate within the hollow microspheres. Important relationships and observations are described that will be useful for gelatin and perhaps other proteinaceous microspheres.

摘要

用于肿瘤内给药的明胶-甲氨蝶呤微球有可能将甲氨蝶呤(MTX)的全身毒性降至最低并克服其耐药性。通过碳二亚胺反应制备的明胶-MTX缀合物与戊二醛交联以形成微球(MTX与明胶的摩尔比为2:1、15:1和21:1)。在体外肿瘤条件下,于pH 6.5和37℃、有和没有组织蛋白酶B(Cat B)的情况下对微球进行评估。一些微球采用乙醇胺/氰基硼氢化钠方法进行封端。破碎微球的扫描电子显微镜显示为中空壳结构。表面Cat B降解影响了一些游离MTX的释放,但未产生缀合物片段的释放。高效液相色谱法测定的片段(<10 kDa)释放量非常少,游离MTX的释放量也很小。然而,载药量较高的微球释放的游离MTX比载药量较低的微球少,封端微球中游离MTX释放的显著滞后阶段在未封端微球中变为初始快速释放,并且片段仅从未封端微球中释放。未封端微球中开放的不稳定席夫碱交联可能使酶产生在封端微球中未观察到的缀合物片段。游离MTX的释放可能来自中空微球内溶解的未交联缀合物。描述了一些重要的关系和观察结果,这些对于明胶以及可能其他蛋白质微球将是有用的。

相似文献

1
Gelatin-methotrexate conjugate microspheres as a potential drug delivery system.明胶-甲氨蝶呤共轭微球作为一种潜在的药物递送系统。
J Pharm Sci. 2006 Sep;95(9):1896-908. doi: 10.1002/jps.20572.
2
Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.明胶/甲氨蝶呤缀合物的生长抑制、药物负载及降解研究
Int J Pharm. 2006 Feb 3;308(1-2):90-9. doi: 10.1016/j.ijpharm.2005.10.037. Epub 2005 Dec 19.
3
Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.用于抗癌药物递送的可生物降解药物靶向系统的制备与表征:微球-抗体缀合物
J Drug Target. 2005 Apr;13(3):151-9. doi: 10.1080/10611860400029069.
4
A novel method to prepare magnetite chitosan microspheres conjugated with methotrexate (MTX) for the controlled release of MTX as a magnetic targeting drug delivery system.一种制备与甲氨蝶呤(MTX)偶联的磁性壳聚糖微球的新方法,用于作为磁性靶向给药系统控制释放MTX。
Drug Deliv. 2009 Jul;16(5):280-8. doi: 10.1080/10717540902989555.
5
Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity.具有相反共轭键极性的甲氨蝶呤/明胶共轭物的表征及甲氨蝶呤的体外释放
Pharm Res. 2000 Oct;17(10):1309-15. doi: 10.1023/a:1026460023503.
6
Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables.使用不同制备变量形成的明胶/甲氨蝶呤缀合物中甲氨蝶呤的表征及体外释放
Int J Pharm. 2000 Aug 25;204(1-2):81-9. doi: 10.1016/s0378-5173(00)00476-2.
7
Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres.抗癌药物甲氨蝶呤从可生物降解明胶微球中的控释。
J Microencapsul. 1994 Jan-Feb;11(1):69-77. doi: 10.3109/02652049409040439.
8
Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint.负载甲氨蝶呤的聚(L-乳酸)微球用于将甲氨蝶呤关节腔内给药至关节。
J Pharm Sci. 2004 Apr;93(4):943-56. doi: 10.1002/jps.20031.
9
Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.甲氨蝶呤的聚乙二醇缀合物,分子量在750至40000之间:体外和体内的合成、表征及构效关系
Bioconjug Chem. 2002 Jul-Aug;13(4):773-85. doi: 10.1021/bc010098m.
10
Preparation and characterization of pH-sensitive proteinoid microspheres for the oral delivery of methotrexate.用于甲氨蝶呤口服递送的pH敏感类蛋白微球的制备与表征
Biomaterials. 1998 Apr-May;19(7-9):725-32. doi: 10.1016/s0142-9612(97)00188-9.

引用本文的文献

1
Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers.双作用药物甲氨蝶呤在不同神经疾病、自身免疫性疾病和癌症中的概述。
Int J Mol Sci. 2020 May 14;21(10):3483. doi: 10.3390/ijms21103483.